BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.84B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
NVIDIA
NVDA
|
+$1.94B |
| 4 |
Amazon
AMZN
|
+$1.5B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.22B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.61B |
| 2 |
Merck
MRK
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$309M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$227M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.57% |
| 2 | Consumer Discretionary | 8.06% |
| 3 | Financials | 7.49% |
| 4 | Healthcare | 6.58% |
| 5 | Communication Services | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
Lineage Cell Therapeutics
LCTX
$271M
| $26.6K | ﹤0.01% |
15,942
+15,782
| +9,864% | +$27.3K |
|
|
BDCIW
4777
BTC Development Corp Warrant
BDCIW
| $26.6K | ﹤0.01% |
+59,118
| New | +$44.5K |
|
|
CARL
4778
Carlsmed
CARL
$391M
| $26.6K | ﹤0.01% |
2,150
-350
| -14% | -$4.66K |
|
4779
Invesco Senior Income Trust
VVR
$459M
| $26.5K | ﹤0.01% |
+8,113
| New | +$26.8K |
|
4780
Patriot National Bancorp
PNBK
$129M
| $26.4K | ﹤0.01% |
14,524
+4,737
| +48% | +$6.53K |
|
4781
Inhibikase Therapeutics
IKT
$378M
| $26.4K | ﹤0.01% |
12,891
-2,749
| -18% | -$4.37K |
|
4782
TScan Therapeutics
TCRX
$52.8M
| $26.4K | ﹤0.01% |
26,360
-3,510
| -12% | -$5.08K |
|
|
KGEI
4783
Kolibri Global Energy
KGEI
$206M
| $26.3K | ﹤0.01% |
6,695
+450
| +7% | +$1.96K |
|
4784
Eastern Company
EML
$153M
| $26.3K | ﹤0.01% |
1,335
+62
| +5% | +$1.27K |
|
4785
ProShares Short Russell2000
RWM
$98.9M
| $26.2K | ﹤0.01% |
1,601
+589
| +58% | +$9.75K |
|
4786
Union Bankshares
UNB
$122M
| $26.2K | ﹤0.01% |
1,103
+365
| +49% | +$8.6K |
|
|
CAPNR
4787
Cayson Acquisition Corp Right
CAPNR
| $26.1K | ﹤0.01% |
+114,486
| New | +$22.1K |
|
|
LATAW
4788
Galata Acquisition Corp II Warrant
LATAW
$1.61M
| $26K | ﹤0.01% |
+74,188
| New | +$30.7K |
|
4789
LENSAR
LNSR
$101M
| $25.7K | ﹤0.01% |
2,211
+203
| +10% | +$2.32K |
|
|
KIO
4790
KKR Income Opportunities Fund
KIO
$456M
| $25.5K | ﹤0.01% |
2,198
+314
| +17% | +$3.72K |
|
|
AOMR
4791
Angel Oak Mortgage REIT
AOMR
$207M
| $25.5K | ﹤0.01% |
2,958
-983
| -25% | -$8.79K |
|
4792
CSP Inc
CSPI
$81.1M
| $25.3K | ﹤0.01% |
2,026
+566
| +39% | +$6.93K |
|
4793
Maui Land & Pineapple Co
MLP
$304M
| $25.1K | ﹤0.01% |
1,480
+47
| +3% | +$758 |
|
4794
KULR Technology Group
KULR
$122M
| $25K | ﹤0.01% |
8,444
+1,488
| +21% | +$5.46K |
|
4795
Evolution Petroleum
EPM
$135M
| $25K | ﹤0.01% |
7,054
-1,140
| -14% | -$4.81K |
|
4796
Lucid Diagnostics
LUCD
$185M
| $24.9K | ﹤0.01% |
22,876
+8,984
| +65% | +$10K |
|
4797
FitLife Brands
FTLF
$101M
| $24.8K | ﹤0.01% |
1,525
-57
| -4% | -$1.05K |
|
|
COLAR
4798
Columbus Acquisition Corp Rights
COLAR
| $24.7K | ﹤0.01% |
+71,696
| New | +$21.2K |
|
4799
Superior Group of Companies
SGC
$208M
| $24.7K | ﹤0.01% |
2,554
+275
| +12% | +$2.69K |
|
|
PNNT
4800
Pennant Park Investment Corp
PNNT
$243M
| $24.7K | ﹤0.01% |
4,139
-649
| -14% | -$4.06K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2025 Portfolio in Review
As of Q4 2025, BNP Paribas Financial Markets held 6,035 positions worth $221B, up 18% from $187B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $25.1B of net new capital in Q4 2025, opening 491 new positions and adding to 2,632 existing holdings. Its largest new stake was Iris Energy: 4,201,138 shares worth $159M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.61B trimmed.
- BNP Paribas Financial Markets's largest Q4 2025 buy was Iris Energy: 4,201,138 shares worth $159M.
- BNP Paribas Financial Markets added most to Microsoft in Q4 2025, an estimated $2.84B increase.
- BNP Paribas Financial Markets's biggest Q4 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.61B.
- BNP Paribas Financial Markets fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $41M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $221B portfolio in Q4 2025.
- BNP Paribas Financial Markets opened 491 new positions and closed 305 in Q4 2025.
- BNP Paribas Financial Markets's portfolio value rose 18% quarter-over-quarter to $221B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.